{"filing":{"accession_number":"0001213900-26-083082","cik":"0001981662","ticker":"NIVFW","company_name":"NewGenIvf Group Ltd","form":"6-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"ea0299803-6k_newgen.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1981662/000121390026083082/ea0299803-6k_newgen.htm"},"events":[{"id":22133,"run_id":20003,"accession_number":"0001213900-26-083082","anchor_item_number":"EX-99.1","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.72,"summary":"The press release discloses an update on NewGen's strategic investment in K25.ai, reporting an unrealized gain of approximately US$8.5 million based on K25.ai's Series A valuation increase to US$200 million, along with the company's 2025 financial results (US$9.9 million net profit, US$25.98 million net assets) and a pending share issuance. While the disclosure includes financial results, the primary focus is the material appreciation of an investment asset and its balance-sheet impact rather than a formal earnings release. This is a financial event—specifically an investment revaluation—that does not fit the discrete `earnings_release` category (which typically announces periodic results as a standalone event) but is material to investor assessment of the company's financial position.","company_name":"NewGenIvf Group Ltd","ticker":"NIVFW","filing_date":"2026-07-30","form":"6-K","submitted_at":null,"items":[{"id":21988,"accession_number":"0001213900-26-083082","item_number":"EX-99.1","item_title":"ea029980301ex99-1.htm","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"The press release discloses an update on NewGen's strategic investment in K25.ai, reporting an unrealized gain of approximately US$8.5 million based on K25.ai's Series A valuation increase to US$200 million, along with the company's 2025 financial results (US$9.9 million net profit, US$25.98 million net assets) and a pending share issuance. While the disclosure includes financial results, the primary focus is the material appreciation of an investment asset and its balance-sheet impact rather than a formal earnings release. This is a financial event—specifically an investment revaluation—that does not fit the discrete `earnings_release` category (which typically announces periodic results as a standalone event) but is material to investor assessment of the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-31T00:01:31.625976+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21988,"accession_number":"0001213900-26-083082","item_number":"EX-99.1","item_title":"ea029980301ex99-1.htm","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"The press release discloses an update on NewGen's strategic investment in K25.ai, reporting an unrealized gain of approximately US$8.5 million based on K25.ai's Series A valuation increase to US$200 million, along with the company's 2025 financial results (US$9.9 million net profit, US$25.98 million net assets) and a pending share issuance. While the disclosure includes financial results, the primary focus is the material appreciation of an investment asset and its balance-sheet impact rather than a formal earnings release. This is a financial event—specifically an investment revaluation—that does not fit the discrete `earnings_release` category (which typically announces periodic results as a standalone event) but is material to investor assessment of the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-31T00:01:31.625976+00:00","company_name":"NewGenIvf Group Ltd","ticker":"NIVFW","filing_date":"2026-07-30"}]}